Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
EV/Core EBITDA

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 24.0322.3216.8914.5814.94

What is the latest EV/Core EBITDA ratio of AJANTA PHARMA ?

The latest EV/Core EBITDA ratio of AJANTA PHARMA is 24.03 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202524.03
Mar202422.32
Mar202316.89
Mar202214.58
Mar202114.94

How is EV/Core EBITDA of AJANTA PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 24.03
7.66
Mar2024 22.32
32.15
Mar2023 16.89
15.84
Mar2022 14.58
-2.41
Mar2021 14.94 -

Other Financial Ratios of AJANTA PHARMA


Compare EV/Core EBITDA ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹31,040.1 Cr -0.7% 1.3% -13% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,034.0 Cr 0.9% 5.3% 1.8% Stock Analytics
DIVIS LABORATORIES ₹169,211.0 Cr -2.3% -3.3% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,875.0 Cr -3.3% 2.8% 19.7% Stock Analytics
CIPLA ₹122,082.0 Cr -1.6% -9.2% 4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,873.0 Cr NA -3.5% 4.6% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-0.7%

1.3%

-13%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses